BAHD1 and head and neck cancer: Herein, we have demonstrated the utility of our platform that led to the discovery of a new pathway for radioresistance involving BAHD1-dependent modification of the heterochromatin that was a dominant molecular phenotype in our RR prostate and head and neck cancer models.